Linkage studies in a series of early onset familial Alzheimer's disease families (EFAD) strongly suggested that the gene is located on chromosome 21 in the region 21q11.1-21q22.2. Two subsequent studies showed that the loci for EFAD and the amyloid (A4) protein were, in fact, 18 centimorgans apart. More recently, linkage studies on later onset families (greater than 60 years) excluded the area where the EFAD gene presumably is located. These results strongly suggest locus heterogeneity in familial Alzheimer's disease. Additional linkage studies are needed in order to: (1) verify the mapping of the EFAD gene to chromosome 21 and (2) to map the gene(s) for later onset FAD. This proposal plans to ascertain and make available the """"""""raw material,"""""""" i.e., cell lines from the most highly informative families in the United States, to researchers who are interested in mapping familial Alzheimer's disease. This proposal plans to ascertain familial cases of AD through the Alzheimer's Association, the ADRCs and the Consortium to Establish an Alzheimer's Disease Registry (CERAD) network. Family history questionnaires will help establish which families are potentially useful. After thorough investigation, those with the greatest potential will be chosen. At least one autopsy verified case will be ascertained and other at-risk family members will be examined. If the family meets the optimum criteria, blood will be obtained and lymphocytes transformed at Indiana and stored in two independent locations. Cell lines will be made available to qualified researchers. Linkage analysis will also be performed for researchers who are not conversant with this aspect of gene mapping.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005128-07
Application #
3809140
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23

Showing the most recent 10 out of 97 publications